COPD

 
Daily Dose: Delay Before Start of Triple Therapy Raises Risk for COPD Exacerbations
October 24, 2022

Your daily dose of clinical news you may have missed.

COPD: Delay Before Start of Triple Therapy May Increase Risk for Exacerbations
October 21, 2022

CHEST. After a moderate COPD event, treatment with TT within 30 days significantly reduced risk for exacerbation over 12 months vs treatment after 30 days.

COPD: Pulmonary Rehab is Effective Regardless of Inhaled Triple Therapy Use
September 15, 2022

In-hospital pulmonary rehabilitation improves function and symptoms in COPD patients whether they are on triple therapy or not, a new study confirms.

Study Underscores Deficits in Management of COPD in Primary Care
August 17, 2022

Findings highlight the need for more real-life studies to support decision making within primary care settings, say researchers.

Smaller Airway Structures Raise Risk for COPD in Women, According to New Research
August 08, 2022

Lung airways were smaller in women than men, even among ever-smokers and never-smokers, according to large analysis.

Inhaler Education with Teach-to-Goal Methods Improved Technique Among Older Adults with Asthma, COPD
August 02, 2022

Additional research into tailored metered-dose inhaler education is needed, according to authors of a recent study.

Continuity of Care for Asthma, COPD Patients Could Improve Survival, Cut Costs
July 08, 2022

When asthma and COPD patients have a continuous relationship with a single provider, ED visits/hospitalizations go down, survival goes up, finds a new systematic review.

Influenza, PPSV23 Vaccines May Reduce Risk for COPD Exacerbations, Hospitalizations
July 01, 2022

In persons with COPD, seasonal influenza and PPSV23 vaccines, separately or together, reduced the risk for COPD- and pneumonia-related hospitalizations.

Glycopyrrolate/formoterol found Noninferior to Tiotropium/formoterol for Improving COPD Symptoms
June 30, 2022

Authors of this first study to compare the combinations head-to-head suggest that the glycopyrrolate combination is appropriate for long-term COPD management.

Pulmonary Rehab Improves Lung Function, QOL in Asthma-COPD Overlap Plus Obesity
April 25, 2022

Asthma-COPD overlap and obesity mutually exacerbate each other and an early program of pulmonary rehabilitation shows promise to help both.